Literature DB >> 15904944

Effect of fraxetin on antioxidant defense and stress proteins in human neuroblastoma cell model of rotenone neurotoxicity. Comparative study with myricetin and N-acetylcysteine.

María Francisca Molina-Jiménez1, María Isabel Sánchez-Reus, María Cascales, David Andrés, Juana Benedí.   

Abstract

Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. Recently, it has been shown that fraxetin (coumarin) and myricetin (flavonoid) have significant neuroprotective effects against apoptosis induced by rotenone, increase the total glutathione levels in vitro, and inhibit lipid peroxidation. Thus, these considerations prompted us to investigate the way in which fraxetin and myricetin affect the endogenous antioxidant defense system, such as Mn and CuZn superoxide dismutase (MnSOD, CuZnSOD), catalase, glutathione reductase (GR), and glutathione peroxidase (GPx) on rotenone neurotoxicity in neuroblastoma cells. N-acetylcysteine (NAC), a potent antioxidant, was employed as a comparative agent. Also, the expression and protein levels of HSP70 by Northern and Western blot analysis were assayed in SH-SY5Y cells. After incubation for 16 h, rotenone significantly increased the expression and activity of MnSOD, GPx, and catalase. When cells were preincubated with fraxetin, there was a decrease in the protein levels and activity of both MnSOD and catalase, in comparison with the rotenone treatment. The myricetin effect was less pronounced. Activity and expression of GPx were increased by rotenone and pre-treatment with fraxetin did not modify significantly these levels. The significant enhancement in HSP70 expression at mRNA and protein levels induced by fraxetin was observed by pre-treatment of cells 0.5 h before rotenone insult. These data suggest that major features of rotenone-induced neurotoxicity are partially mediated by free radical formation and oxidative stress, and that fraxetin partially protects against rotenone toxicity affecting the main protection system of the cells against oxidative injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15904944     DOI: 10.1016/j.taap.2005.04.009

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  14 in total

1.  Molecular responses differ between sensitive silver carp and tolerant bighead carp and bigmouth buffalo exposed to rotenone.

Authors:  Jon J Amberg; Theresa M Schreier; Mark P Gaikowski
Journal:  Fish Physiol Biochem       Date:  2012-03-25       Impact factor: 2.794

2.  Prophylactic neuroprotective propensity of Crocin, a carotenoid against rotenone induced neurotoxicity in mice: behavioural and biochemical evidence.

Authors:  Sriranjini Venkata Rao; P Hemalatha; S Yetish; M Muralidhara; Padmanabhan S Rajini
Journal:  Metab Brain Dis       Date:  2019-06-18       Impact factor: 3.584

3.  Behavioral, neuroplasticity and metabolic effects of 7,8-dihydroxy-4-methylcoumarin associated with physical activity in mice.

Authors:  Priscilla Karla Fernandes Lopes; Daiane Fátima Engel; Natalia Oliveira Bertolini; Moisés Silvestre de Azevedo Martins; Chrystian Araujo Pereira; Licio Augusto Velloso; Sérgio Scherrer Thomasi; Rodrigo Ferreira de Moura
Journal:  Metab Brain Dis       Date:  2021-10-02       Impact factor: 3.584

4.  Epigallocatechin gallate (EGCG) potentiates the cytotoxicity of rotenone in neuroblastoma SH-SY5Y cells.

Authors:  Woon-Gye Chung; Cristobal L Miranda; Claudia S Maier
Journal:  Brain Res       Date:  2007-08-22       Impact factor: 3.252

5.  Transcriptome analysis of a rotenone model of parkinsonism reveals complex I-tied and -untied toxicity mechanisms common to neurodegenerative diseases.

Authors:  Yofre Cabeza-Arvelaiz; Robert H Schiestl
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

6.  Effects of Semelil (ANGIPARS™) on diabetic peripheral neuropathy: A randomized, double-blind Placebo-controlled clinical trial.

Authors:  S Bakhshayeshi; Sp Madani; M Hemmatabadi; R Heshmat; B Larijani
Journal:  Daru       Date:  2011       Impact factor: 3.117

7.  Nanoemulsion Improves the Neuroprotective Effects of Curcumin in an Experimental Model of Parkinson's Disease.

Authors:  Osmar Vieira Ramires Júnior; Barbara da Silva Alves; Paula Alice Bezerra Barros; Jamile Lima Rodrigues; Shana Pires Ferreira; Linda Karolynne Seregni Monteiro; Gabriela de Moraes Soares Araújo; Sara Silva Fernandes; Gustavo Richter Vaz; Cristiana Lima Dora; Mariana Appel Hort
Journal:  Neurotox Res       Date:  2021-04-16       Impact factor: 3.978

8.  Fraxetin alleviates microglia-mediated neuroinflammation after ischemic stroke.

Authors:  Shi-Ji Deng; Jian-Wei Ge; Sheng-Nan Xia; Xin-Xin Zou; Xin-Yu Bao; Yue Gu; Yun Xu; Hai-Lan Meng
Journal:  Ann Transl Med       Date:  2022-04

9.  Diquat causes caspase-independent cell death in SH-SY5Y cells by production of ROS independently of mitochondria.

Authors:  R Nisar; P S Hanson; L He; R W Taylor; P G Blain; C M Morris
Journal:  Arch Toxicol       Date:  2015-02-19       Impact factor: 5.153

10.  Fraxetin Induces Heme Oxygenase-1 Expression by Activation of Akt/Nrf2 or AMP-activated Protein Kinase α/Nrf2 Pathway in HaCaT Cells.

Authors:  Juthika Kundu; In Gyeong Chae; Kyung-Soo Chun
Journal:  J Cancer Prev       Date:  2016-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.